Immunohistochemical analysis of p53, Ki-67, CD44, HER-2/neu expression patterns in gastric cancer, and their association with one-year survival in north-west of Iran

International Journal of Hematology-Oncology and Stem Cell Research

Volumn 7, Issue 3, 2013, Pages 14-19

  Sanaat, Zohreh ^a   Halimi, Monireh ^a   Ghojezadeh, Morteza ^a   Pirovi, Amir Hossein ^a   Gharamaleki, Jalil Vaez ^a   Ziae, Ali Esfahani Jamal Eivazi ^a   Kermani, Iraj Aswadi ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

Author keywords

CD 44; Gastric cancer; HER 2 neu; Ki 67; P53

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HERMES ANTIGEN; KI 67 ANTIGEN; PROTEIN P53;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE REGULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; ONCOGENE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER; SURVIVAL TIME; TISSUE CHARACTERIZATION;

EID: 84880451971     PISSN: 17351243     EISSN: 20082207     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med.1995; 333: 32-41.
2. Kato Y, Nakamura S, Arai K, Konishi T, Takeshita K, Sano T, et al. Meeting report: the 75th Congress of the Japanese Gastric Cancer Association. Gastric Cancer.2004; 7: 3-8.
3. Morales TG. Adenocarcinoma of the gastric cardia. Dig Dis. 1997; 15: 346-356.
4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial progression. Cancer Res. 1992; 52:6735-6740.
5. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Volgeman JH, Orentreich N, et al. Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med.1991; 325: 1127-1131.
6. Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and metaanalysis. Int J Cancer. 1997; 72: 565-573.
7. DaVita Vincent T., Lawrence, Theodore S., Rosenberg, Steven A. Hellman & Rosenberg's Cancer, Principles & Practice of Oncology, 8th Edition, Lippincott Williams & Wilkins.2008;989-992.
8. Smith MG, Hold GL, Tahara E, El-Omar EM. Cellular and molecular aspects of gastric cancer. World J Gastroenterol. 2006; 12:2979-2990.
9. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol.2006; 12:354-362.
10. Milner J, Watson JV. Addition of fresh medium induces cell cycle and conformational changes in p53, a tumor suppressor protein. Oncogene. 1990; 5: 1683-1690.
11. Azarhoush R, Keshtkar AA, Amiriani T, Kazemi-Nejad V. Relationship between p53 Expression and Gastric Cancers in Cardia and Antrum. Arch Iran Med, 2008; 11(5):502-6.
12. Staib F, Robeles AI, Varticovski l, Wang XW. The tumor suppressor network is a key responder to microinvironmental components of chronic inflammatory stress. cancer res, 2005; 65(22):122-55.
13. Jovanović I, Todorović V, Milosavljević T, Micev M, Pesko P. et al. Expression of p53 protein in Barrett's adenocarcinoma and adenocarcinoma of the gastric cardia and antrum. Vojnosanit Pregl, 2005; 62(12):879-85.
14. Al-Moundhri MS, Nirmala V, Al-Hadabi I, Al-Mawaly K, Burney I, et al. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/HER-/neu, and KI-67 proteins expression in gastric cancer: a clinic pathological and Immunohistochemical study of 121 Arab patients. J Surg Oncol, 2005; 15; 91(4):243-52.
15. Park DI, Yun JW, Park JH, Oh SJ, Kim HJ, et al. HER-2/neuamplification is an independent prognostic factor in gastric cancer. Dig Dis Sci, 2006; 51(8):1371-9.
16. Orita H, Maehara Y, Emi Y, Kakeji Y, Baba H, Korenaga D, Sugimachi K. c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma. Hepatogastroenterology.1997; 44:294-298.
17. Joo M, Lee HK, Kang YK. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Anticancer Res, 2003; 23(2B):1581-8.
18. Hsieh HF, Yu JC, Ho LI, Chiu SC, Harn HJ. Molecular studies into the role of CD44 variants in metastasis in gastric cancer. Mol Pathol, 1999; 52(1):25-8.
19. Sneath RJ, Mangham DC. The normal structure and function of CD44 and its role in neoplasia. Mol Pathol, 1998; 51(4):191-200.
20. Wakamatsu Y, Sakamoto N, Oo Hz. Expresion of cancer stem cell markers ALDH1, CD44, and CD133 in primary tumor and lymph node metastasis of gastric cancer;pathol Int.2012;62(2):112-9.
21. Byung Ik Jang, Yuan Li, David Y. Graham, and Putao Cen. The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer. Gut Liver, 2011; 5(4): 397-405.
22. Shigeo T, Tomoyuki O, Shiuping TSophie S. Wataru S, Ramanathan V. et al. Identification of gastric cancer stem cells using the cell surface marker CD44. alphaMed Press,2009;l27(5), 1006-1020.
23. Shafigh E, Abdolazimi Y, Shafaie Sh, Hajiahmadi M. Expression of biomarkers Ki-67, p27KIP1, p53 in gastric cancer andtheir association with histopathologic indicators of gastrectomy samples of patients reffered to Shahid Beheshti hospital Babol Iran in2000-2006. Univ Med Scienc Babol. 2007; 9(4):7.
24. Yao zheng, Lin wang, Jian ping. expression of p53, c-erbB and KI-67 in intestinal met aphasia and gastric carcinoma. world j gastroenterol, 2010: 21; 13(23):3189-98.
25. Shiao YH, Rugge M. p53 alteration in gastric precancerous lesions. Am J Pathol.1994; 144(3):511.
26. LI JH, Shi XZ, Lv S, Liu M (2005). Effect of helicon bacter on p53 expression of gastric mucosa and adenocarcinoma with micro satellite instability. World J Gastroenterol,2005;11(28):4363.
27. N E Tzanakis, G Peros, P Karakitsos. (2009). prognostic significans of p53 and KI-67 proteins expression in Greek gastric cancer patients. ActaChirurgica Belgica,2009;109(5):606-611.
28. Wanyi Tai, Rubi Mahato, and Kun Cheng. The role of HER-2/NEU in cancer therapy and targeted drug delivery. J Control Release, 2010; 15; 146(3): 264-275.
29. Cathy B. Moelans, Paul J. van Diest, Anya N Milne, and Johan G.A. Offerhaus. SAGE-Hindawi. Access to Research Pathology Research International, 2011:10.
30. Fredrik Petersson, Kurt Borch, Lennart E. Franzén. Gastric Epithelial Proliferation and p53 and p21 Expression in a General Population SampleRelations to Age, Sex, and Mucosal Changes Associated with H. pylori Infection. Digestive disease and science, 2006; 47(7)145-56.
31. Gomyo Y, Ikeda M, Osaki M, et al. Expression of P21 (waf1/cip1/sdi1), but not P53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer, 1997; 79(11): 2067-72.
32. E. U. Cidon, R. G. Centeno, E. G. Lagarto, J. I. Peral. HER-2 Evaluation in a Specific Gastric Cancer Population with the Highest Rate of Mortality in Spain. Journal of Oncology, 2011: 6.
33. Shi-Yan Yan, Ying Hu, Jian-Gao Fan, Guo-Quan Tao, Yong-Ming Lu, Xu Cai, Bao-Hua Yu, Yi-Qun Du. Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma. World J Gastroenterol. 2011;17(11): 1501-1506